Incident hepatitis C virus in women with human immunodeficiency virus infection

被引:15
作者
Augenbraun, M
Goedert, JJ
Thomas, D
Feldman, J
Seaberg, EC
French, AL
Robison, E
Nowicki, M
Terrault, N
机构
[1] SUNY Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
[3] NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA
[4] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[5] Rush Med Coll, CORE Ctr, Cook Cty Hosp, Chicago, IL 60612 USA
[6] Univ So Calif, Los Angeles, CA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.1086/379075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Individuals infected with human immunodeficiency virus type 1 (HIV-1) are frequently coinfected with hepatitis C virus (HCV). Acute HCV infection is often asymptomatic and poorly understood. We conducted a historical prospective study of HCV antibody and viremia in plasma samples obtained during 1994-1999 from a cohort of initially HIV-1-infected, HCV-uninfected women and from HIV-1-HCV-uninfected women. Twenty-two (1.5%) of 1517 experienced seroconversion. Of these, 14 (64%) truly acquired a new infection as assessed by enzyme immunoassay response and new-onset viremia. The incidence rate in HIV-1-infected women was 2.7 cases per 1000 person-years; it was 3.3 cases per 1000 person-years in HIV-1-seronegative women (relative risk, 1.21; P = .75). Acquisition of HCV was associated with any history of drug use (P < .01). Five of 12 viremic, seroconverting individuals cleared viremia. Incident HCV infection among HIV-1-infected and HIV-1-uninfected women was low. It was linked to drug use and commonly resolved.
引用
收藏
页码:1357 / 1364
页数:8
相关论文
共 30 条
[1]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[2]  
ALTER MJ, 1997, HEPATOLOGY S1, V26, P62
[3]   The Women's Interagency HIV Study [J].
Barkan, SE ;
Melnick, SL ;
Preston-Martin, S ;
Weber, K ;
Kalish, LA ;
Miotti, P ;
Young, M ;
Greenblatt, R ;
Sacks, H ;
Feldman, J .
EPIDEMIOLOGY, 1998, 9 (02) :117-125
[4]   Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion [J].
Beld, M ;
Penning, M ;
van Putten, M ;
van den Hoek, A ;
Damen, M ;
Klein, MR ;
Goudsmit, J .
BLOOD, 1999, 94 (04) :1183-1191
[5]   Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters [J].
Beld, M ;
Penning, M ;
Lukashov, V ;
McMorrow, M ;
Roos, M ;
Pakker, N ;
van den Hoek, A ;
Goudsmit, J .
VIROLOGY, 1998, 244 (02) :504-512
[6]   HIGH HEPATITIS-C VIREMIA AND IMPAIRED ANTIBODY-RESPONSE IN PATIENTS COINFECTED WITH HIV [J].
CRIBIER, B ;
REY, D ;
SCHMITT, C ;
LANG, JM ;
KIRN, A ;
STOLLKELLER, F .
AIDS, 1995, 9 (10) :1131-1136
[7]  
de Oliveira JM, 2001, J MED VIROL, V63, P265, DOI 10.1002/1096-9071(200104)63:4&lt
[8]  
265::AID-JMV1000&gt
[9]  
3.0.CO
[10]  
2-V